Blumenfeld AM, Charleston L 4th, Kuruvilla D, Savage-Edwards B, et al. OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trial. Headache 2025 Dec 15. doi: 10.1111/head.70007.
PMID: 41393002